Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 24.92 AUD 1.38%
Market Cap: 8.4B AUD

EV/S
Enterprise Value to Sales

10.3
Current
11
Median
7.7
Industry
Lower than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
10.3
=
Enterprise Value
8.1B AUD
/
Revenue
783.2m AUD

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
6.3
2-Years Forward
EV/S
4.9
3-Years Forward
EV/S
4.2